Donald Trump, the president-elect, has chosen Mark Meador, a former staffer for Utah Senator Mike Lee, to serve as a commissioner on the Federal Trade Commission (FTC). The FTC oversees competition and consumer protection enforcement, a role that aligns with Meador’s extensive antitrust experience.
According to Bloomberg, Meador is no stranger to the FTC or the Justice Department’s antitrust division, having worked with both agencies early in his career. He spent approximately five years at the FTC focusing on antitrust cases and later transitioned to the Justice Department for over two years. His expertise in competition policy was further honed during his tenure as an advisor to Senator Lee, the ranking Republican on the Senate antitrust subcommittee. In that role, Meador helped draft legislation targeting tech giants, including a proposal to dismantle Google’s advertising technology operations. This proposal addresses issues currently at the heart of a Department of Justice antitrust lawsuit.
In private practice, Meador co-founded a law firm with a former colleague of Jonathan Kanter, the outgoing head of the Justice Department’s antitrust division. His advocacy has included representing clients facing competitive challenges, such as conservative social media platforms like Rumble, which seek to carve out space in a market dominated by larger rivals.
Related: Trump Announces Andrew Ferguson as FTC Chair Nominee Amid Antitrust Policy Uncertainty
Meador’s selection is notable for his reputation as a pro-enforcement Republican with a populist bent, particularly regarding the tech industry. Bloomberg reports that Meador was also considered for a minority party seat on the FTC under President Joe Biden, highlighting his bipartisan recognition in competition law circles.
This announcement follows Trump’s earlier decision on Tuesday to appoint Andrew Ferguson as the FTC’s chair, replacing Lina Khan. The role of chair is critical and often politically charged, given the FTC’s influence over major issues involving technology, healthcare, and other industries.
Source: Bloomberg
Featured News
Federal Judge Dismisses Class Action Alleging Inflated Yacht Commission Fees
Jan 22, 2025 by
CPI
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Johns Hopkins and Caltech Settle for $35.3M in College Price-Fixing Lawsuit
Jan 22, 2025 by
CPI
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan